Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2008 Oct 14;14(38):5927-9.
doi: 10.3748/wjg.14.5927.

Intraperitoneal dedifferentiated liposarcoma: a case report

Affiliations
Case Reports

Intraperitoneal dedifferentiated liposarcoma: a case report

Ali Karaman et al. World J Gastroenterol. .

Abstract

Dedifferentiated liposarcoma is a variant of liposarcoma with a more aggressive course. Mutations of the p53 gene have been found in different types of soft tissue sarcoma. It is generally accepted that p53 mutations in human malignant tumors are often related to a poor prognosis. In our case, analysis of p53 gene mutation in tumor samples was performed. p53 gene mutation was observed in dedifferentiated tumor tissue samples but not in well-differentiated tumor tissue samples. It has been reported that p53 gene mutation occurs most commonly in the retroperitoneum and rarely in other anatomic locations. Herein we report a case of dedifferentiated liposarcoma located at intraperitoneum.

PubMed Disclaimer

Figures

Figure 1
Figure 1
T1-weighted magnetic resonance image (MRI) demonstrating a high-intensity mass.
Figure 2
Figure 2
Well-differentiated tumor shows numerous lipoblasts and the dedifferentiated tumor resembles pleomorphic, spindle cells with hyperchromatic nuclei (HE, × 100) in the area revealing an abrupt transition from the well-differentiated to the dedifferentiated tumor (A), and dedifferentiated tumor shows low cellularity, fusiform cells with small hyperchromatic nuclei, and abundant collogen in the low grade fibrosarcoma area (B) (HE, × 100).
Figure 3
Figure 3
Amplification of the BstU1 within exon 4 produces a 66 bp long segment while cleavage results in 37 bp and 29 bp long fragments. Lane 1: No mutation of p53 gene in well-differentiated tumor; lane 2: Mutation of p53 gene in dedifferentiated tumor; lane 3: DNA marker.

Similar articles

Cited by

References

    1. Fletcher CDM, Unni KK, Mertens F. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of soft tissue and bone. Lyon: IARC Press; 2002. pp. 40–44, 227-232.
    1. Ichikawa A, Kinoshita T, Watanabe T, Kato H, Nagai H, Tsushita K, Saito H, Hotta T. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med. 1997;337:529–534. - PubMed
    1. de Anta JM, Jassem E, Rosell R, Martínez-López E, Jassem J, Monzó M, Sánchez-Hernández JJ, Moreno I, Sánchez-Céspedes M. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis. Oncogene. 1997;15:2951–2958. - PubMed
    1. Taubert H, Meye A, Wurl P. Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients. Cancer Res. 1996;56:4134–4136. - PubMed
    1. Drobnjak M, Latres E, Pollack D, Karpeh M, Dudas M, Woodruff JM, Brennan MF, Cordon-Cardo C. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J Natl Cancer Inst. 1994;86:549–554. - PubMed

Publication types

Substances